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Background 
Emergency contraception is using a drug or copper intra-
uterine device to prevent pregnancy shortly after 
unprotected intercourse.  
Inclusion criteria 
Studies:  
Randomized controlled trials.  
Participants: 
Women with regular menses requesting emergency 
contraception following unprotected intercourse. 
Intervention: 
Intervention: any method of emergency contraception. 
Control: no intervention or placebo; different 
formulations; different doses. 
Outcomes: 
Primary: pregnancy;  
Adverse events: early menses, delayed menses, any 
other adverse event. 
Results 
• Eighty-one trials of 45,842 women were included; 22 
trials had adequate allocation concealment. 
• Mifepristone prevented more pregnancies than: 
◊ the Yuzpe regimen-oestrogen and 
progestogen within 72 hrs-  (relative risk 
0.14, 95% confidence interval 0.05 to 0.41; 
2144 women, 3 trials) 
◊ levornogestrel (RR 2.01, 95% CI 1.27 to 
3.17; 3743 women, 15 trials) 
◊ danzanol (RR 0.10, 95% CI 0.02 to 0.55; 
629 women, 2 trials) 
◊ andorin (RR 0.26, 95% CI 0.11 to 0.63; 
1035 women, 7 trials). 
• Mifepristone was also associated with fewer adverse 
events. 
• In comparisons between mid-dose (25-50 mg) and low
-dose (<25 mg) mifepristone, mid-dose was 
associated with fewer pregnancies (RR 0.67, 95% CI 
0.49 to 0.92; 11,432 women, 20 trials) but 
menstruation was more commonly delayed (RR 1.32, 
95% CI 1.15 to 1.51; 10,919 women, 17 trials). 
• High dose (>50 mg) compared with mid-dose 
mifepristone, (3009 women, 9 trials) was associated 
with more adverse events and delayed menses, but no 
additional protection from pregnancy. 
• Levornogestrel compared with the Yuzpe regimen was 
associated with fewer pregnancies (RR 0.51, 95% CI 
0.31 to 0.83; 2789 women, 2 trials) and fewer adverse 
events. 
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Which emergency contraceptive method is best? 
Single dose of mifepristone (25–50 mg) is effective with least side-effects. 
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Authors’ conclusions 
Implications for practice:  
Emergency contraception is effective for preventing pregnancy. Mifepristone (25–50 mg) is the most effective and 
best tolerated hormonal method when compared with other regimens and doses. Levornogestrel is more effective 
and better tolerated than the Yuzpe regimen.  
Levornogestrel vs mifepristone mid-dose (25-50 mg): number of pregnancies 
 
